Nephros Inc (NEPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 140 | 1,194 | 1,132 | 795 | 558 |
| Depreciation Amortization | 27 | 139 | 107 | 73 | 40 |
| Accounts receivable | -1,107 | -633 | -880 | -259 | -896 |
| Other Working Capital | -1,989 | -413 | -96 | 253 | -458 |
| Other Operating Activity | 1,258 | 1,358 | 1,152 | 454 | 1,078 |
| Operating Cash Flow | $-1,671 | $1,645 | $1,415 | $1,316 | $322 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -1 | -5 | -4 | -2 | -1 |
| Common Stock Issued | 290 | N/A | N/A | N/A | N/A |
| Financing Cash Flow | $289 | $-5 | $-4 | $-2 | $-1 |
| Beginning Cash Position | 5,400 | 3,760 | 3,760 | 3,760 | 3,760 |
| End Cash Position | 4,018 | 5,400 | 5,171 | 5,074 | 4,081 |
| Net Cash Flow | $-1,382 | $1,640 | $1,411 | $1,314 | $321 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,671 | 1,645 | 1,415 | 1,316 | 322 |
| Free Cash Flow | -1,671 | 1,645 | 1,415 | 1,316 | 322 |